Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.

Dubensky, Thomas W; Kanne, David B; Leong, Meredith L

Dubensky, Thomas W; Kanne, David B; Leong, Meredith L.

Afiliação

Dubensky TW; Aduro BioTech, Inc., 626 Bancroft Way, 3C, Berkeley, CA, 94710, USA.
Kanne DB; Aduro BioTech, Inc., Berkeley, CA, USA.
Leong ML; Aduro BioTech, Inc., Berkeley, CA, USA.

Ther Adv Vaccines ; 1(4): 131-43, 2013 Nov.

Article em En | MEDLINE | ID: mdl-24757520

Palavras-chave

STING; adjuvant; cellular immunity; cyclic dinucleotides; cytosolic nucleic acid sensing; formulation; innate immunity; stimulator of interferon genes; vaccine

Texto completo